Skip to main content
Premium Trial:

Request an Annual Quote

Brad Wertz

Brad Wertz, chairman and founding investor of GenomOncology, will take over as CEO on Jan. 1, the Cleveland-based company announced. Manuel Glynias, GenomOncology's current CEO and founder, will remain president. Wertz has a history of scaling technology companies in various industries as they move from startup to growth phase, including bioinformatics software maker Acero. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.